EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Wharton's Jelly‐Derived Hybrid Scaffolds for Tissue Engineering Applications

Claudio Nastruzzi

Macromolecular Bioscience · 2026-07 · 26 (7)

DOI: 10.1002/mabi.70211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, online erschienen am 08.07.2026. Verfasst von Claudio Nastruzzi. Beteiligte Einrichtung: Dipartimento di Scienze Chimiche, Farmaceutiche e Agrarie, Università di Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Tissue Engineering, Tissue Scaffolds, Wharton Jelly. Die Arbeit nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regenerative medicine is increasingly pivoting toward acellular, bio‐instructive strategies that leverage the biomimetic potential of the extracellular matrix (ECM). Among neonatal tissues, Wharton's Jelly (WJ) has emerged as a primary source of bioactive molecules, structural proteins, and growth factors essential for tissue repair. This progress report provides a comprehensive analysis of decellularized Wharton's Jelly (DWJ) and its integration into advanced hybrid scaffold systems, with a particular focus on the engineering of alginate‐based composites. While standalone DWJ scaffolds provide a biomimetic environment rich in collagen and glycosaminoglycans, they often lack the mechanical robustness required for load‐bearing clinical applications. The synergy between WJ and polymers—processed through 3D bioprinting, microencapsulation, and lyophilization—overcomes these limitations, offering highly tunable degradation and structural integrity. Furthermore, we highlight the emergence of “smart” bio‐instructive systems (2024–2025), which integrate WJ‐derived exosomes and stimuli‐responsive elements to coordinate cell‐free tissue repair in situ. By evaluating applications in cartilage, bone, neural, and intervertebral disc regeneration, this review underscores the potential of WJ‐hybrid platforms to serve as next‐generation therapeutic tools in translational clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringTissue ScaffoldsWharton JellyHumansAlginatesRegenerative MedicineDecellularized Extracellular MatrixAnimalsPrinting, Three-DimensionalExtracellular Matrix

Stichwörter der Autor:innen

3D bioprintingalginate hybrid scaffoldsdecellularized extracellular matrix (dECM)exosome deliverytissue engineeringwharton's jelly

Substanzen

AlginatesDecellularized Extracellular Matrix

Autor:innen und Institutionen

  • Dipartimento di Scienze Chimiche, Farmaceutiche e Agrarie, Università di Ferrara, Ferrara, Italy.

Zitieren

APA

Nastruzzi, C. (2026). Wharton's Jelly‐Derived Hybrid Scaffolds for Tissue Engineering Applications. Macromolecular Bioscience, 26(7). https://doi.org/10.1002/mabi.70211

Vancouver

Nastruzzi C. Wharton's Jelly‐Derived Hybrid Scaffolds for Tissue Engineering Applications. Macromolecular Bioscience. 2026;26(7). doi:10.1002/mabi.70211

BibTeX
@article{Nastruzzi2026,
  author = {Nastruzzi, Claudio},
  title = {Wharton's Jelly‐Derived Hybrid Scaffolds for Tissue Engineering Applications},
  journal = {Macromolecular Bioscience},
  year = {2026},
  volume = {26},
  number = {7},
  doi = {10.1002/mabi.70211}
}
Kostenlos starten →